LRMR (Larimar Therapeutics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Larimar Therapeutics, Inc. Common Stock (LRMR) is a publicly traded Healthcare sector company. As of May 21, 2026, LRMR trades at $3.48 with a market cap of $336.58M and a P/E ratio of 0.00. LRMR moved +5.71% today. Year to date, LRMR is +5.06%; over the trailing twelve months it is +71.36%. Its 52-week range spans $1.61 to $9.50. Analyst consensus is strong buy with an average price target of $16.00. Rallies surfaces LRMR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns LRMR stock?
Hedge funds tracked by Rallies that own LRMR include Mangrove Partners. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Larimar Therapeutics, Inc. Common Stock.
LRMR Key Metrics
Key financial metrics for LRMR
Metric
Value
Price
$3.48
Market Cap
$336.58M
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$9.50
52-Week Low
$1.61
Volume
214
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-165.67M
Gross Margin
0.00%
Top Hedge Funds Holding LRMR
Mangrove Partners holds 442.24K shares of LRMR, changed -42.58% as of Sep 30, 2025.
Hedge funds tracked by Rallies that own LRMR include Mangrove Partners. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Larimar Therapeutics, Inc. Common Stock.
Does Rallies show 13F holders for LRMR?
Yes. Rallies tracks hedge fund and 13F ownership data for LRMR, including fund names, share counts, latest tracked quarter, and position changes when available.
Is LRMR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for LRMR. It does not provide personalized investment advice.
